Filing Details

Accession Number:
0001209191-12-054432
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-23 16:50:53
Reporting Period:
2012-11-20
Filing Date:
2012-11-23
Accepted Time:
2012-11-23 16:50:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1389072 Heartware International Inc. HTWR Surgical & Medical Instruments & Apparatus (3841) 980498958
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1404227 Evan Douglas Godshall C/O Heartware International, Inc.
205 Newbury Street, Suite 101
Framingham MA 01701
President & Chief Exec Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-11-20 8,572 $0.00 66,399 No 4 M Direct
Common Stock Disposition 2012-11-21 223 $81.78 66,176 No 4 S Direct
Common Stock Disposition 2012-11-21 1,109 $82.88 65,067 No 4 S Direct
Common Stock Disposition 2012-11-21 688 $83.91 64,379 No 4 S Direct
Common Stock Disposition 2012-11-21 1,682 $84.85 62,697 No 4 S Direct
Common Stock Disposition 2012-11-21 76 $85.79 62,621 No 4 S Direct
Common Stock Disposition 2012-11-21 39 $87.00 62,582 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. On July 31, 2009 the reporting person was granted restricted stock units to purchase an aggregate of 34,285 shares of common stock. The award vested in three installments based on HeartWare's satisfaction of certain performance criteria. The performance criteria of the third installment of the award was met on November 20, 2012 resulting in the issuance of 8,572 shares of common stock to the reporting person.
  2. These shares were sold pursuant to a pre-arranged trading plan in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The sale proceeds were utilized to pay all payroll taxes related to the vesting of restricted stock units and receipt of the related shares reported on this Form 4.
  3. The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $81.45 to $82.10. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  4. The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $82.50 to $83.49. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  5. The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $83.55 to $84.48. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  6. The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $84.55 to $85.53. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  7. The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $85.75 to $85.82. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.